Trial intelligence / Profile preview

Ekzevowen derma in mild to moderate atopic dermatitis (half-side, vehicle-controlled)

2004-002594-23Phase 4Completed

Sponsor
Weber & Weber
Start
Jan 2005
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Ekzevowen derma in atopic dermatitis (AD) (2 arms), sponsored by Weber & Weber. Primary endpoint: Local SCORAD. Started Jan 2005; status: completed.

02

Drugs

Ekzevowen derma
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2004-002594-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002594-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call